Purchase this article with an account.
Pete Coffey; Animal models of ARMD and RPE transplant in human patients. Journal of Vision 2008;8(17):39. doi: 10.1167/8.17.39.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
The London Project to Cure Blindness aims to make the most of human embryonic stem cells to prevent blindness and restore sight in patients with age-related macular degeneration (AMD) by 2011. Our goal is to replace cells essential for “seeing” lost by disease at the back of the eye. We aim to repair and regenerate the aged diseased eye using human embryonic stem cells which have been transformed into the cells affected in AMD: the support cells for the photoreceptors (retinal pigment epithelium) and the photoreceptors. The cells will be surgically implanted into a clinical population of AMD patients.
This PDF is available to Subscribers Only